Patrick Fabbio

Patrick Fabbio currently works at BeyondSpring, Inc., as Independent Director from 2018 and Protara Therapeutics, Inc., as Chief Financial Officer from 2023.
Mr. Fabbio also formerly worked at NPS Pharmaceuticals, Inc., as Vice President-Finance from 2012 to 2015, Biomatrix, Inc., as Controller, Progenics Pharmaceuticals, Inc., as Chief Financial Officer, Secretary & Senior VP, Ikano Therapeutics, Inc., as Chief Financial Officer from 2009 to 2011, Coopers & Lybrand (London), as Auditor, Catalent Pharma Solutions, Inc., as Vice President-Finance, Innovation & Growth, electroCore, Inc., as Chief Financial Officer, WindMIL Therapeutics, Inc., as Chief Financial Officer from 2020 to 2021, and Rafael Holdings, Inc., as Chief Financial & Accounting Officer in 2023.
Mr. Fabbio received his undergraduate degree from Pace University and Masters Business Admin degree from The Leonard N Stern School of Business.